LEMAITRE VASCULAR, INC. Proceeds from Lines of Credit
LEMAITRE VASCULAR, INC. (LMAT) reported Proceeds from Lines of Credit of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2023-03-01
- LEMAITRE VASCULAR, INC. proceeds from lines of credit for the quarter ending 2021-12-31 was $0.00.
- LEMAITRE VASCULAR, INC. proceeds from lines of credit for the quarter ending 2021-09-30 was $0.00.
- LEMAITRE VASCULAR, INC. proceeds from lines of credit for the quarter ending 2020-12-31 was $0.00.
- LEMAITRE VASCULAR, INC. proceeds from lines of credit for the quarter ending 2020-09-30 was $0.00.
- LEMAITRE VASCULAR, INC. proceeds from lines of credit for fiscal 2022 was $0.00.
- LEMAITRE VASCULAR, INC. proceeds from lines of credit for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- LEMAITRE VASCULAR, INC. proceeds from lines of credit for fiscal 2020 was $25.00M.
- LEMAITRE VASCULAR, INC. proceeds from lines of credit for fiscal 2019 was $0.00.
| Period end | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 6 month | Proceeds from Lines of Credit 9 month | Proceeds from Lines of Credit 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-01 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | $0.00 10-K · filed 2023-03-01 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-05 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | $25.00M 10-K · filed 2023-03-01 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $25.00M 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $25.00M 10-Q · filed 2021-08-05 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $0.00 10-K · filed 2022-02-28 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $0.00 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-06 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |